Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
6.90
-0.64 (-8.49%)
At close: Aug 28, 2026, 4:00 PM EDT
6.92
+0.02 (0.29%)
After-hours: Aug 28, 2026, 7:45 PM EDT
Niki BioSolutions Market Cap
Niki BioSolutions has a market cap or net worth of $20.28 million as of August 28, 2026. Its market cap has increased by 26.15% in one year.
Market Cap
20.28M
Enterprise Value
21.95M
1-Year Change
26.15%
Ranking
Category
Stock Price
$6.90
ChartMarket Cap Chart
Since December 18, 2018, Niki BioSolutions's market cap has decreased from $415.79M to $20.28M, a decrease of -95.12%. That is a compound annual growth rate of -32.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 20.28M | 134.89% |
| Dec 31, 2025 | 8.63M | -45.03% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Marker Therapeutics | 22.84M |
| Allarity Therapeutics | 22.43M |
| Dyadic International | 22.38M |
| ABVC BioPharma | 21.52M |
| Longeveron | 21.42M |
| Cocrystal Pharma | 21.19M |
| Akari Therapeutics, | 20.83M |
| Neuphoria Therapeutics | 20.32M |